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Objective: To examine the multiplication efﬁciency Japanese encephalitis virus (JEV)
genotype I (GI) and genotype III (GIII) of different cell lines which originated from
human, porcine, mosquitoes in order to prove mechanism of JEV GI replacement JEV
GIII since it emerging in nature recent decades.
Methods: The mixture of GI and GIII JEV isolates was inoculated on human rhabdo-
myosarcoma (RD), pig kidney epithelial (PS) and Aedes albopictus C6/36 clone (C6/36)
which originated from human, porcine and mosquitoes, respectively. Plaque assays were
performed to calculate virus titer and real-time RT-PCR with GI and GIII speciﬁc primer
sets to quantify the number of GI and GIII RNA copies.
Results: The highest virus titer reached at the 3rd day of post infection when GI and GIII
mixture was inoculated on RD and PS and that of C6/36 was at the 4th day. JEVs were
ampliﬁed and maintained by C6/36 cells after 10 passages whereas that by RD and PS
only limited within 8 and 6 passages, respectively. GI strain ampliﬁed and maintained
more efﬁciently on C6/36 and PS but not RD, whereas GIII strain ampliﬁed and main-
tained more efﬁciently on RD.
Conclusions: There is a correlation between the multiplication efﬁciency of GI and GIII
JEV strains when these two genotype strains co-infected on different cell lines with the
predominance of GI strains in C6/36 and PS and the limited detection of GI strains in RD
cells proving a possible mechanism of shift JEV genotypes in nature recent decades since
GI emerging.1. Introduction
Japanese encephalitis virus (JEV) is a mosquito-borne virus
of the genus Flavivirus in the family Flaviviridae which has
circulated widely in Asian and western Paciﬁc countries, and in
northern Australia [1,2]. Approximately 67900 cases of JE
typically occur annually and 10000–15000 JEV-related human
deaths are reported annually [2,3]. JEV is transmitted to
susceptible reservoirs by arthropods with the mainly
involvement of mosquitoes, especially Culex tritaeniorhynchus
whereas pigs, horses, birds and bats are the primary naturalhosts of JEV. Humans are the dead-end host in which JEV
could not be transmitted from humans to humans.
The JEV genome consists of a single-stranded positive-sense
RNA in which the open reading frame encodes a large poly-
protein. The N-terminal region of the polyprotein encodes the
structural proteins: Capsid (C)-pre-membrane (prM)-Envelope
(E) and the non-structural proteins (NS) (NS1-NS2A-NS2B-NS3-
NS4-NS5) [4]. JEV is classiﬁed into ﬁve genotypes based on the
nucleotide sequences of the C/prM and E protein genes [5].
However, all ﬁve genotypes have been detected in mosquitoes
and reservoirs while the number of genotypes detected in
humans is limited. While JEV genotypes I and III are
predominant in humans, only two of JEV genotype II strains
were detected so far; one in Australia and the other in Korea [5,6].
In humans, genotype I (GI) strains have displaced genotype
III (GIII) strains to become the predominant genotype in many
countries [7]. The emergence of JEV GI strains was ﬁrst
identiﬁed in mosquitoes and pigs in northern Asian countries,
Korea in 1993 and Japan in 1994 [8–10] and in mosquitoes inticle under the CC BY-NC-ND license (http://
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isolated from mosquitoes and swine while very few have been
isolated from humans [11,12]. Therefore, the JEV GI strains are
supposed more adapting to mosquitoes and pigs than to
humans [14]. Among twelve haplotypes that are deﬁned based
on the four amino acid residues in the E protein (sites 123,
209, 227, and 408), the haplotypes and the host ranges of the
GI isolates are narrower than those of the GIII isolates [15].
To identify the adaptation of JEV GI and GIII strains in
different host species experimentally, we conducted the study to
examine the multiplication of JEV GI and GIII strains when
these two genotypes co-infected in different cell lines which
originate from human, porcine and mosquitoes. This study aims
to prove an evidence of the mechanism shift JEV genotypes in
nature recent decades since JEV GI emerging in most of Asian
countries where JEV GIII circulating before.
2. Material and methods
2.1. Cell and viruses
Pig kidney epithelial (PS); human rhabdomyosarcoma (RD);
mosquito Aedes albopictus C6/36 clone (C6/36), baby hamster
kidney-21 cells were maintained in minimum essential medium
(MEM) supplemented with 10% fetal bovine serum. The cells
were incubated at 37 C with 5% CO2 except C6/36 cell was
incubated at 28 C. The Japanese encephalitis virus (JEV) strain
93VN118 and 94VN141 were originally detected from
mosquitoes in 1993 and 1994, respectively. Their genotypes
were identiﬁed as genotype I-b (GI-b) (94VN141) and genotype
I (GI) (93VN118) (GenBank accession number AB933310 and
AB933311) [12]. Those virus strains were chosen because they
are the ﬁrst JEV GI and the last JEV GIII to be detected from
mosquitoes in the Northern Vietnam. Virus stocks were stored
at −80 C until examined.2.2. Viral infection
The virus titers of two isolates were determined by plaque
assay, and then diluted to be at the same titer (100 PFU/mL) in
MEM with 2% fetal calf serum (FCS).
The mixture of two strains whose titer was 100 PFU/mL was
inoculated on the monolayer of RD, PS and C3/36 cell lines for
60 min at 37 C and 28 C, respectively. The un-absorbed viruses
were removed from cells. The infected RD, PS cells were incu-
bated at 37 C in a humidiﬁed 5% CO2 atmosphere and C6/36 in
28 C. The supernatants were harvested continuously for 5 d after
inoculation in order to determine time-point when virus titers
reached peak by using plaque assay. The virus mixture was then
inoculated continuously 10 passages on RD, PS and C3/36 cell
lines. The supernatants were harvested at the determined peak day
in every passage and stored at −80 C. Plaque assays were per-
formed to determine which cell line could maintain and amplify
JEV efﬁciently and TaqMan RT-PCR were performed to deter-
mine which genotype ampliﬁed efﬁciently by each cell line.2.3. Plaque assay
Serial ten-fold dilutions of JEV GI and GIII mixture at each
determined time-point were prepared in chilled MEM with 2%
FCS from 10−1 to 10−6. Diluted virus samples were inoculatedon three cell lines and then MEM with 2% FCS plus with 1.25
methylcellulose was overlaid after viral absorption for 90 min.
Each dilution was performed in triplicate. The baby hamster
kidney-21 cells were incubated at 37 C with 5% CO2 for 7 d.
Cells then were stained with 0.1% crystal violet after saline
formal ﬁxation for demonstration of plaques. The excess stain
was washed off with tap water; air-dried. The number of plaques
was measured in each well and calculated the virus titer. Plaque
assays were repeated three times at the same conditions.
2.4. RNase treatment and nucleic acid extraction from
supernatant
In order to measure only RNAs of JEV on the cell, before RNA
extraction, the infected supernatants were treated with RNase.
One unit of Rnase A (Qiagen Science, Germantown, MD, USA)
diluted 1:10 or 1:100 with nuclease free water was added to
200mL of each sample and incubated at 37 C for 30min. RnaseA
activity, thereafter was inhibited by 18U of Rnase inhibitor
(Qiagen) and incubated at room temperature for 30 min. The
RNAs were then extracted using QIAamp Viral RNA Mini Kit
(Qiagen) according to the manufacturer's instructions.
2.5. TaqMan real-time RT-PCR assay
JEV GI and GIII strains quantiﬁcation was performed sepa-
rately after each passage with a speciﬁc primer set with Super-
Script® III Platinum® One-Step qRT-PCR Kit w/o ROX
(Invitrogen, Carlsbad, CA, USA) as described previously.
For GIdetection, forward primer (50-GGGGACAAGCA-
GATTAACCA-30), reverse primer (50-GAAGGCACCAC-
CAAACACTT-30) were used at a ﬁnal concentration of 0.2 mM
and probe (FAM-TCAACAACTTTGAAAGGGGC-36TAMSp)
at a ﬁnal concentration of 0.1 mM. The same primer concentration
was used for GIII, primer set with forward primer (50-
CCTTGCAAAATTCCGATTGT-30), reverse primer (50-
TGAGCTCCCTTCAAAGTCGT-30) and probe (FAM-
CTGGTGACAGTGAACCCCTT-36TAMSp). An Eppendorf
Mastercycler ep Realplex (Eppendorf AG, Hamburg, Germany),
was used for analysis. The thermal proﬁle included incubation at
50 C for 15min, at 95 C for 2min for reverse transcription. DNA
was ampliﬁed with 40 cycles at 95 C for 15 s, 60 C for 30 s.3. Results
3.1. Determination of time-point of virus titer peak on
different cell-lines
To determine the time point when virus titers in the super-
natant were the highest, we inoculated the virus mixture on three
cell-lines: PS, RD and C6/36. With the same virus titer inocu-
lation (100 PFU/mL) and the same virus mixture volume
(100 mL), the highest mixture virus titers reached after 3 d post
infection (p.i.) on PS (1.3 × 103 PFU/mL) and RD
(1.6 × 105 PFU/mL), and 4 d pi. on C6/36 (7.2 × 105) when
measured by plaques assay (Figure 1).
3.2. Most efﬁcient cell-line for JEV multiplication
When continuously inoculated 10 passages on cell-lines, the
virus was maintained by C6/36 during 10 passages and the
Figure 1. Multiplication kinetics by time post infection of JEV mixture of
strains representative of GI and GIII genotype in C6/36, RD and PS cell
lines.
Figure 3. Multiplication kinetics of strains representative of GI and GIII
genotype when co-infected in C6/36, PS and RD cells.
a: C6/36 cell line; b: PS cell line; c: RD cell line.
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mL) but not by PS or RD. The virus titer could not be deter-
mined after the 6th passage when virus mixture was inoculated
on PS and after the 8th passage when the virus mixture was
inoculated on RD (Figure 2).
3.3. Multiplication of GI and GIII strains in human,
porcine and mosquito cells
After 93VN118 strain (GIII) and 94VN141 strain (GI) was
mixed and continuously passage using PS, RD and C6/36, the
numbers of RNA copy of each strain after each passage were
quantiﬁed indirectly through Ct value (the higher RNA copies,
the lower Ct value) by real-time RT-PCR using GI/GIII speciﬁc
genotype primer sets.
In C6/36, Ct value of 94VN141 strain (GI) was lower than
93VN118 strain (GIII) meaning that the virus titer of GI strain
was higher than that of GIII strain at all 10 passages (Figure 3a).
Although GI strain was ampliﬁed more efﬁciently in C6/36 than
GIII strain but both genotype strains were maintained during 10
passages because its RNA copies still could be detected by real-
time RT-PCR at 10th passage.
On PS cell-line, both GI and GIII decreased gradually after
each passage but the dead-end circle point of GIII strain was
after 6th passage and that of GI strain was after 7th and 8th
passage (Figure 3b) meaning that GI strain was maintained
longer than GIII by RD cell-line.Figure 2. Multiplication kinetics within ten passages of JEV mixture of
strains representative of GI and GIII genotype in C6/36, RD and PS cells.On RD cell-line, the GI strain decreased gradually and dis-
appeared after 5th passage gradually but GIII strain increased
and got peak at 3rd passage and decreased gradually after that.
However, GIII strain was maintained longer than GI strain when
the dead-end point was after 8th passage (Figure 3c).
4. Discussion
The study was examined the ampliﬁcation and maintenance
capacity of three different cell-lines which originated from
humans, porcine and mosquitoes, the three main components of
JEV cycle in nature to the most two predominant JEV geno-
types. The virus titer reached peak on C6/36 1 d later than that
on RD and PS. It is worthy to note that multiplication of GI-b
strains increased when the temperature increased [7] and the
incubation temperature of C6/36 cells is 28 C and that of RD
and PS cell is 37 C. GI-b strains were also proven to be
temperate genotype whereas GIII is signiﬁcantly associated with
temperate climates [16].
C6/36 was the most effective tool to isolate JEV since the
JEV strains could multiply and maintain high titer after 10
passages whereas the multiplication of JEV was limited within
6–8 passages when viruses were inoculated on PS and RD.
When two genotype strains (GI and GIII) were co-infected
in vitro, GI-b strain ampliﬁed more efﬁciently than GIII strains
on C6/36 and PS cells whereas GIII strain ampliﬁed more efﬁ-
ciently on RD cells than GI-b strain showed that GI-b strains
increased viral multiplication on C6/36 cells compared to GI-a
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maintain itself on RD cells, and disappeared after 5 passages.
Although there were differences between in vitro and natural
condition such as C6/36 cells lack a functional RNA interference
response [7], the results provided some pieces of experimental
explanation to the predominant and replacement of GI strains
to GIII strains in mosquitoes and pigs [7,17] and very few GI
strains have been isolated from humans [12,13].
There is a correlation between the high multiplication efﬁ-
ciency of GI JEV strains when two genotype strains, GI and
GIII, were co-infected on porcine and mosquito cells with the
predominant of GI strains in mosquitoes and porcine and the
limited detection of GI strains in humans. The high multiplica-
tion efﬁciency of GIII strains on humans also corrected well with
the predominant of GIII strain in humans.
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